1994
DOI: 10.1073/pnas.91.11.4902
|View full text |Cite
|
Sign up to set email alerts
|

Stable intrachain and interchain complexes of neurofilament peptides: a putative link between Al3+ and Alzheimer disease.

Abstract: The etiologic role ofAl3+ in Alzhelmer disease has been controversial. Circular dichroism (CD) spectrscopic studies on two synthetic Mfrgments of human neurofilament protein mid-sized subunit (NF-M), NF-M13 (KSPVPKSP-VEEKG) and NF-M17 (EEKGKSPVPKSPVEEKG), and their alanine-substituted and/or serine-phosphorylated derivatives were carried out in an attempt to find a molecular mechanm for the effect of A13+ to induce aggregation of neuronal proteins or their catabolic frments. AP+ and Ca2+ ions were found to ind… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
20
0
4

Year Published

1995
1995
2015
2015

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(24 citation statements)
references
References 36 publications
0
20
0
4
Order By: Relevance
“…Of these, Al has been considered to be one of the most important factors (Kawahara 1999) contributing to the development of dialysis dementia (Alfrey et al 1976), Parkinson's disease (Good & Olanow 1992), amyotrophic lateral sclerosis (Yasui et al 1991), and AD (Hollosi et al 1994). Based on cumulative observations indicating that a neurotoxin was expressed when Al was parenterally administered to mammals (Clayton et al 1992;Lipman et al 1988), and those wherein hemodialysis patients exposed to high concentrations of Al showed a decline in their memory, attention, and concentration (Bolla et al 1992), Al accumulation in the brain was assumed to induce neuropathy, thereby developing the initial symptom of AD.…”
Section: Discussionmentioning
confidence: 98%
“…Of these, Al has been considered to be one of the most important factors (Kawahara 1999) contributing to the development of dialysis dementia (Alfrey et al 1976), Parkinson's disease (Good & Olanow 1992), amyotrophic lateral sclerosis (Yasui et al 1991), and AD (Hollosi et al 1994). Based on cumulative observations indicating that a neurotoxin was expressed when Al was parenterally administered to mammals (Clayton et al 1992;Lipman et al 1988), and those wherein hemodialysis patients exposed to high concentrations of Al showed a decline in their memory, attention, and concentration (Bolla et al 1992), Al accumulation in the brain was assumed to induce neuropathy, thereby developing the initial symptom of AD.…”
Section: Discussionmentioning
confidence: 98%
“…16,26,28,29 With the increasing bioavailability of this metal ion due to acid rain witnessed in the last decades, the study of the relationship between its levels in biological uids, and tissues and its potential involvement in neurological disorders, has gained a renewed interest. 25,27 In most natural systems, the aluminum absorption, excretion, tissue retention and deposition will depend on the properties of the Al 3+ complexes formed with biological ligands.…”
Section: +mentioning
confidence: 99%
“…Zn 2+ at physiologically plausible concentrations rapidly precipitated soluble AB1-40 into protease-resistant aggregates in vitro [53]. Findings in neurofilament peptides strongly suggest a role of Al 3+ in AD tangle and plaque formation [54]. Al 3+ markedly enhanced synthetic BA aggregation.…”
Section: Metal Cationsmentioning
confidence: 83%